• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Physiological and pathological functions of a novel prion-like protein, PrPLP/Dpl.

Research Project

Project/Area Number 13470065
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Virology
Research InstitutionNagasaki University

Principal Investigator

KATAMINE Shigeru  Nagasaki University, Graduate School of Biomedical Sciences, Professor, 大学院・医歯薬学総合研究所, 教授 (40161062)

Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥14,300,000 (Direct Cost: ¥14,300,000)
Fiscal Year 2003: ¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2002: ¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2001: ¥6,900,000 (Direct Cost: ¥6,900,000)
Keywordsprion diseases / prion protein / prion-like protein / gene-knockout mice / neurodegeneration / 海綿状変性
Research Abstract

Certain lines of mice devoid of prion protein (PrP), such as Ngsk Prnp^<0/0>, exhibit late-onset ataxia due to Purkinje cell degeneration, which is rescued by a transgene encoding PrP. In these mice, PrP-like protein, PrPLP/Dpl, is ectopically expressed by neurons including Purkinje cells and glial cells. To explore mechanisms of the neurodegeneration, two types of transgenic (tg) mice expressing PrPLP/Dpl in all neurons, tg(N-PrPLPIDpI), or only Purkinje cells, tg(P-PrPLP/Dpl), were generated and subsequently backcrossed with non-ataxic Zrch I Prnp^<0/0> mice to eliminate the Prnp alleles. In contrast to the tg mice with the Prnp^<+/+> background, never showing neurological abnormalities, not only tg(N-PrPLP/Dpl) but also, tg(P-PrPLP/Dpl) mice with the Prnp^<0/0> alleles developed Purkinje cell degeneration after incubation periods inversely correlated to the expression levels of PrPLP/Dpl. Moreover, some of the tg mice hemizygous for Prnp allele (Prnp^<0+>) also succumbed to the dise … More ase but much later than those carrying the Prnp^<0/0> alleles. These results indicated that PrPLP/Dpl ectopically expressed by Purkinje cells itself executes a does-dependent deleterious effect on the cells, and that a stoichiometric antagonistic interaction between PrP and PrPLP/Dpl is crucially involved in the neurodegeneration. We next introduced five types of PrP transgenes including heterologous hamster and two mouse/hamster chimeric genes as well as two mutants, each of which encoded PrP lacking residues 23-88 (MHM2.del23-88) or with E199K substitution (Mo.E199K), into Ngsk Prnp^<0/0> mice. Only MHM2.de123-88 failed to rescue from the Purkinje cell death. Little difference was observed in pathology and onset of ataxia between Ngsk Prnp^<0/0> and MHM2.de123-88/Ngsk Prnp^<0/0>. No detergent-insoluble PrPLP/Dpl was detectable in the CNS of Ngsk Prnp^<0/0> even after the onset of ataxia. Our findings provide evidence that the N-terminal residues 23-88 of PrP containing the unique octapeptide-repeat region is crucial for preventing Purkinje cell death in the Prnp^<0/0> mice expressing PrPLP/Dpl in the neuron. Less

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Furukawa H, Doh-ura K, Okuwaki R, Shirabe S, amamoto K, Udono H, Ito T, Katamine S, Niwa M: "A pitfall in diagnosis of human prion diseases using detection of protease-resistnt prion protein in urine : Contamination with bacterial outer membrane proteins."J Biol Chem. (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Atarashi R, Nishida N, Shigematsu K, Goto S, Kondo T, Sakaguchi S, Katamine S: "Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to reue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration."J Biol Chem. 278(31). 28944-28949 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Watarai U, Kim S, Erdenebaatar J, Uakino S, Horiuchi M, Shirahata T, Sakaguchi S, Katamine S: "Cellular prion protein promotes Brucella infection into macrophages"J Exp Med.. 198(1). 5-17 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yukitake M, Satoh J, Katamine S, Kuroda Y: "EAAT4 mRNA expression is preserved in the cerebellum of prion protein-deficient mice."Neurosci Lett. 352(3). 171-174 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Atarashi, R., Sakaguchi, S., Shigematsu, K., Arima, K., Okimura, N., Yamaguchi, N., Li, A., Kopacek, J., Katamine, S: "Abnormal activation of glial cells in the brains of prion protein-deficient mice ctopically expressing prion protein-like protein, PrPLP/Dpl."Mol.Med.. 7(12). 803-809 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Lehmann S, Laude H, Harris DA, Carp RI, Vilette D, Katamina S, Madec J-Y, Nishida N: "Ex vivo transmission of mouse-adapted prion strains to N2a and GT1-7 cell lines."In Alzheimer's Disease : Advances in Etiology, Pathogenesis and Therapeutics. 679-686 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 片峰茂: "プリオン病「ウイルス学からみた医療の安全性」(栗村敬編集)"メデイカルビュー杜. 169-174 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 片峰茂: "プリオンと遅発性ウイルス感染症「標準微生物学 第8版」(山西弘一、平松啓一編集)"医学書院. 533-537 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 片峰茂: "プリオン病「図説分子病態学(3版)」(一瀬白帝、鈴木宏治編著)"中外医学社. 368-371 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Furukawa H, Doh-ura K, Okuwaki R, Shirabe S, Yamamoto K, Udono H, Ito T, Katamine S, Niwa M: "A pitfall in diagno sis of human prion diseases using detection of protease-resistant prion protein in urine : Contamination with bacterial outer membrane proteins."J Biol Chem.. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Atarashi R, Nishida N, Shigematsu K, Goto S, Kondo T, Sakaguchi S, Katamine S: "Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration."J Biol Chem.. 278(31). 28944-28949 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Watarai M, Kim S, Erdenebaatar J, Makino S, Horiuchi M, Shirahata T, Sakaguchi S, Katamine S: "Cellular prion protein promotes Brucella infection into macrophages."J Exp Med.. 198(1). 5-17 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yukitake M, Satoh J, Katamine S, Kuroda Y: "EAAT4 mRNA expression is preserved in the cerebellum.of prion protein-deficient mice."Neurosci Lett.. 352(3). 171-174 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Atarashi, R., Sakaguchi, S., Shigematsu, K Anima, K., Okimura, N., Yamaguchi, N.Li, A., Kopacek, J., Katamine, S.: "Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl."Mol.Med. 7(12). 803-809 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Lehmann S, Laude H, Harris DA, Carp RI, Vilette D, Katamine S, Madec J-Y, Nishida N.: "Ex vivo transmission of mouse adapted prion strains to N2a and GT1-7 cell lines. Alzheinzer's Disease : Advances in Etiology"Pathogenesis and Therapeutics. 679-686 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Atarashi R et al.: "Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration"J Biol Chem.. 278・31. 28944-28949 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Watarai M et al.: "Cellular prion protein promotes Brucella infection into macrophages"J Exp Med.. 198・1. 5-17 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yukitake M et al.: "EAAT4 mRNA expression is preserved in the cerebellum of prion protein-deficient mice"Neurosci Lett. 352・3. 171-174 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Atarashi, R.et al.: "Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dp1"Mol.Med.. 7・12. 803-809 (2001)

    • Related Report
      2003 Annual Research Report
  • [Publications] Lehmann S et al.: "Ex vivo transmission of mouse-adapted prion strains to N2a and GT1-7 cell lines"In Alzheimer's Disease : Advances in Etiology, Pathogenesis and Therapeutics. 679-686 (2001)

    • Related Report
      2003 Annual Research Report
  • [Publications] Lehmann S: "Ex vivo transmission of mouse-adapted prion strains to N2a and GT1-7 cell lines"Alzheimer's Disease : Advances in Etiology, Pathogenesis and Therapeutics. 679-686 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Atarashi, R: "Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl"Molecular Medicine. 7(12). 803-809 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi